New strategies in allogeneic stem cell transplantation: Immunotherapy using irradiated allogeneic T cells

Bone Marrow Transplantation

Volumn 25, Issue , 2000, Pages S20-S24

  Waller, E K ^a   Boyer, M ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

Allogeneic bone marrow transplantation; Immunotherapy; Irradiated lymphocytes; Relapse

Indexed keywords

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL EXPERIMENT; CLINICAL TRIAL; CONFERENCE PAPER; GRAFT VERSUS HOST REACTION; IMMUNOTHERAPY; MOUSE; NONHUMAN; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SPLEEN CELL; STEM CELL TRANSPLANTATION; T LYMPHOCYTE;

ANIMALS; CELL SURVIVAL; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; GRAFT VS TUMOR EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOTHERAPY; LEUKEMIA; LYMPHOMA, NON-HODGKIN; MICE; MICE, CONGENIC; MICE, INBRED C57BL; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 0033934036     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702347     Document Type: Article

References (15)

1. Weiden PL, Sullivan KM, Fluomoy N et al. Antileukemic effect of graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. New Engl J Med 1981; 304: 1529-1533.
2. Barrett AJ, Horowitz MM, Gale RP et al. Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survival. Blood 1989; 74: 862-871.
3. O'Reilly R. Allogeneic bone marrow transplantation: current status and future directions. Blood 1983; 62: 941-964.
4. Thomas ED, Buckner CD, Clift R et al. Marrow transplantation for acute nonlymphoblastic leukemia in first remission. New Engl J Med 1979; 301: 597-599.
5. Collins RH, Shpilberg O, Drobyski WR et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 1997; 15: 433-444.
6. Kolb H, Schattenberg A, Goldman J et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 1995; 86: 2041-2050.
7. Zeder K, Waller EK, Redei I et al. Impact of donor lymphocyte infusion for hematological malignancy relapsed after allogeneic bone marrow transplantation. Cancer Res Ther Control 1998; 5: 221-228.
8. Lu PH, Negrin RS. A novel population of expanded human CD3 CD56 cells derived from T cells with potent in vivo antitumor activity in mice with severe combined. J Immunol 1994; 153: 1687-1696.
9. Muraoka S, Miller RG. Cells in murine fetal liver and in lymphoid colonies grown from fetal liver can suppress generation of cytotoxic T lymphocytes directed against their self antigens. J Immunol 1983; 131: 45-49.
10. Cesano A, Pearson G, Visonneau S et al. Use of a lethally irradiated major histocompatibility complex nonrestricted cytotoxic T-cell line for effective purging of marrow's containing lysis-sensitive or-resistant leukemic targets. Blood 1996; 87: 393-403.
11. Gratwohl A, Baldomero H, Nissen C Speck B. Engraftment of T-cell depleted rabbit bone marrow. Acta Haematol 1987; 77: 208-214.
12. Deeg HJ, Storb R, Weiden PL et al. Abrogation of resistance to and enhancement of DLA-nonidentical unrelated marrow grafts in lethally irradiated dogs by thoracic duct lymphocytes. Blood 1979; 53: 552-587.
13. Bean MA, Graham T, Appelbaum F et al. Gamma irradiation of blood products prevents rejection of subsequent DLA-identical marrow grafts. Transplantation 1996; 61: 334-335.
14. Waller EK, Ship AM, Mittelstaedt S et al. Irradiated donor leukocytes promote engraftment of allogeneic bone marrow in major histocompatability complex mis-matched recipients without causing graft-versus-host disease. Blood 1999; 94: 1-14.
15. Boise LH, Minn AJ, Noel PJ et al. CD28 costimulation can promote T cell survival by enhancing the expression of Bclxl. Immunity 1996; 3: 87-98.